Page last updated: 2024-10-29

iohexol and ADPKD

iohexol has been researched along with ADPKD in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ruggenenti, P1
Gaspari, F1
Cannata, A1
Carrara, F1
Cella, C1
Ferrari, S1
Stucchi, N1
Prandini, S1
Ene-Iordache, B1
Diadei, O1
Perico, N1
Ondei, P1
Pisani, A1
Buongiorno, E1
Messa, P1
Dugo, M1
Remuzzi, G1

Other Studies

1 other study available for iohexol and ADPKD

ArticleYear
Measuring and estimating GFR and treatment effect in ADPKD patients: results and implications of a longitudinal cohort study.
    PloS one, 2012, Volume: 7, Issue:2

    Topics: Adult; Cohort Studies; Disease Progression; Female; Glomerular Filtration Rate; Humans; Iohexol; Mal

2012